These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1388 related items for PubMed ID: 16224390

  • 1. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U, Erhardtsen E.
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [Abstract] [Full Text] [Related]

  • 2. General haemostatic agents--fact or fiction?
    Hedner U.
    Pathophysiol Haemost Thromb; 2002 Feb; 32 Suppl 1():33-6. PubMed ID: 12214145
    [Abstract] [Full Text] [Related]

  • 3. Recombinant factor VIIa: its background, development and clinical use.
    Hedner U.
    Curr Opin Hematol; 2007 May; 14(3):225-9. PubMed ID: 17414211
    [Abstract] [Full Text] [Related]

  • 4. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
    Allen GA, Hoffman M, Roberts HR, Monroe DM.
    Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
    [Abstract] [Full Text] [Related]

  • 5. To general haemostasis--the evidence-based route.
    Erhardtsen E.
    Pathophysiol Haemost Thromb; 2002 Dec; 32 Suppl 1():47-52. PubMed ID: 12214148
    [Abstract] [Full Text] [Related]

  • 6. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
    Veldman A, Hoffman M, Ehrenforth S.
    Curr Med Chem; 2003 May; 10(10):797-811. PubMed ID: 12678684
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of action of factor VIIa in the treatment of coagulopathies.
    Hedner U.
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():77-85. PubMed ID: 16673269
    [Abstract] [Full Text] [Related]

  • 8. Transfusion medicine service policies for recombinant factor VIIa administration.
    Goodnough LT, Lublin DM, Zhang L, Despotis G, Eby C.
    Transfusion; 2004 Sep; 44(9):1325-31. PubMed ID: 15318856
    [Abstract] [Full Text] [Related]

  • 9. Recombinant factor VIIa (NovoSeven) as a hemostatic agent.
    Hedner U.
    Dis Mon; 2003 Jan; 49(1):39-48. PubMed ID: 12525827
    [Abstract] [Full Text] [Related]

  • 10. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM.
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of action, development and clinical experience of recombinant FVIIa.
    Hedner U.
    J Biotechnol; 2006 Aug 05; 124(4):747-57. PubMed ID: 16697480
    [Abstract] [Full Text] [Related]

  • 12. Recombinant factor VIIa (Novoseven) as a hemostatic agent.
    Hedner U.
    Semin Hematol; 2001 Oct 05; 38(4 Suppl 12):43-7. PubMed ID: 11735110
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of action of recombinant activated factor VII: an update.
    Hedner U.
    Semin Hematol; 2006 Jan 05; 43(1 Suppl 1):S105-7. PubMed ID: 16427375
    [Abstract] [Full Text] [Related]

  • 14. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
    Livnat T, Zivelin A, Martinowitz U, Salomon O, Seligsohn U.
    J Thromb Haemost; 2006 Jan 05; 4(1):192-200. PubMed ID: 16409469
    [Abstract] [Full Text] [Related]

  • 15. Tissue factor-independent effects of recombinant factor VIIa on hemostasis.
    Weeterings C, Lisman T, de Groot PG.
    Semin Hematol; 2008 Apr 05; 45(2 Suppl 1):S12-5. PubMed ID: 18544417
    [Abstract] [Full Text] [Related]

  • 16. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.
    He S, Blombäck M, Jacobsson Ekman G, Hedner U.
    J Thromb Haemost; 2003 Jun 05; 1(6):1215-9. PubMed ID: 12871322
    [Abstract] [Full Text] [Related]

  • 17. Dosing with recombinant factor viia based on current evidence.
    Hedner U.
    Semin Hematol; 2004 Jan 05; 41(1 Suppl 1):35-9. PubMed ID: 14872419
    [Abstract] [Full Text] [Related]

  • 18. Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis.
    Hedner U, Ezban M.
    Annu Rev Med; 2008 Jan 05; 59():29-41. PubMed ID: 17845136
    [Abstract] [Full Text] [Related]

  • 19. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
    Campbell RA, Fischer TH, Wolberg AS.
    Br J Haematol; 2007 Jul 05; 138(1):82-93. PubMed ID: 17555451
    [Abstract] [Full Text] [Related]

  • 20. The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.
    He S, Ekman GJ, Hedner U.
    J Thromb Haemost; 2005 Feb 05; 3(2):272-9. PubMed ID: 15670032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.